Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Röcken

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
The Journal of Clinical Investigation|May 27, 2010
Early tumor dissemination, but late metastasis: insights into tumor dormancyMartin Röcken
Experimental Dermatology|April 22, 2009
Mast cells: novel clinical perspectives from recent insightsManfred Kneilling, Martin Röcken
The Journal of Investigative Dermatology|March 27, 2022
A Commotion in the Skin: Developing Melanoma ImmunotherapiesEllen Brenner, Martin Röcken
Current Drug Targets. Inflammation and Allergy|June 8, 2004
Immune deviation strategies in the therapy of psoriasisKamran Ghoreschi, Martin Röcken
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 22, 2005
[Immunopathogenesis of psoriasis]Kamran Ghoreschi, Martin Röcken
Expert Opinion on Drug Discovery|March 14, 2013
Interleukin 4 as a potential drug candidate for psoriasisChristina Weigert, Martin Röcken, Kamran Ghoreschi
Clinics in Dermatology|November 21, 2007
Immunopathogenesis and role of T cells in psoriasisKamran Ghoreschi, Christina Weigert, Martin Röcken
Drug News & Perspectives|April 5, 2008
Angiogenesis: the new potential target for the therapy of psoriasis?Regina Heidenreich, Martin Röcken, Kamran Ghoreschi
Journal of Molecular Medicine (Berlin, Germany)|July 25, 2003
A molecule solves psoriasis? Systemic therapies for psoriasis inducing interleukin 4 and Th2 responsesKamran Ghoreschi, Ulrich Mrowietz, Martin Röcken
Experimental Dermatology|April 18, 2007
Calcineurin inhibitors and rapamycin: cancer protection or promotion?Maren Weischer, Martin Röcken, Mark Berneburg
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
The Journal of Clinical Investigation|May 27, 2010
Early tumor dissemination, but late metastasis: insights into tumor dormancyMartin Röcken
Experimental Dermatology|April 22, 2009
Mast cells: novel clinical perspectives from recent insightsManfred Kneilling, Martin Röcken
The Journal of Investigative Dermatology|March 27, 2022
A Commotion in the Skin: Developing Melanoma ImmunotherapiesEllen Brenner, Martin Röcken
Current Drug Targets. Inflammation and Allergy|June 8, 2004
Immune deviation strategies in the therapy of psoriasisKamran Ghoreschi, Martin Röcken
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 22, 2005
[Immunopathogenesis of psoriasis]Kamran Ghoreschi, Martin Röcken
Expert Opinion on Drug Discovery|March 14, 2013
Interleukin 4 as a potential drug candidate for psoriasisChristina Weigert, Martin Röcken, Kamran Ghoreschi
Clinics in Dermatology|November 21, 2007
Immunopathogenesis and role of T cells in psoriasisKamran Ghoreschi, Christina Weigert, Martin Röcken
Drug News & Perspectives|April 5, 2008
Angiogenesis: the new potential target for the therapy of psoriasis?Regina Heidenreich, Martin Röcken, Kamran Ghoreschi
Journal of Molecular Medicine (Berlin, Germany)|July 25, 2003
A molecule solves psoriasis? Systemic therapies for psoriasis inducing interleukin 4 and Th2 responsesKamran Ghoreschi, Ulrich Mrowietz, Martin Röcken
Experimental Dermatology|April 18, 2007
Calcineurin inhibitors and rapamycin: cancer protection or promotion?Maren Weischer, Martin Röcken, Mark Berneburg
Pageof 16